CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia. [PDF]
Martín-Herreros B +18 more
europepmc +1 more source
From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia. [PDF]
Rasouli M +4 more
europepmc +1 more source
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. [PDF]
Whetstone C +17 more
europepmc +1 more source
Differential Expression Profiles of Orphan Nuclear Receptors (NR4A) and N-myc Downstream-Regulated Gene Family (NDRG) in Patients with Inflammatory Bowel Disease. [PDF]
Fonseca-Camarillo G +5 more
europepmc +1 more source
Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting. [PDF]
Feng S, Kong R, Xiao L, Zhou X.
europepmc +1 more source
Impressive Skin and Systemic Response Despite Patient Underestimation and Delayed Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]
Pacini E +7 more
europepmc +1 more source
The transformative potential of lipid nanoparticles tailored for acute myeloid leukemia immunotherapy. [PDF]
Kamb A, Welch JS.
europepmc +1 more source
Overexpression of TREM1 predicts poor prognosis and chemotherapy resistance in Egyptian acute myeloid leukemia associated with FLT3 internal tandem duplication and CD123 expression and stemness signatures. [PDF]
Mansor SG +4 more
europepmc +1 more source

